Angiotensin II-generating enzymes, angiotensin-converting enzyme ACE and mast cell chymase CMA1, in gastric inflammation may be regulated by H. pylori and associated cytokines

Pathology

Volumn 41, Issue 5, 2009, Pages 419-427

  Carl Mcgrath, Stacy ^a   Grntzdrffer, Ilona ^a   Lendeckel, Uwe ^b   Ebert, Matthias P ^c   Rcken, Christoph ^a  

^a Charité Campus Benjamin Franklin Medical Center   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Angiotensin II; Ectopeptidase; Immunohistochemistry; Inflammation

Indexed keywords

ANGIOTENSIN II; CHYMASE; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR BETA 1; UNCLASSIFIED DRUG;

ADULT; APICAL MEMBRANE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; ENZYME LOCALIZATION; FEMALE; GASTRITIS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GRANULATION TISSUE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MAST CELL; MICROVASCULATURE; PROTEIN EXPRESSION; PYLORUS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH ANTRUM; STOMACH CHIEF CELL; STOMACH EPITHELIUM; STOMACH ULCER;

EID: 70350648640     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020902885037     Document Type: Article

References (69)

1. Re RN. Tissue renin angiotensin systems. Med Clin North Am 2004; 88: 19-38.
2. Smith GR, Missailidis S. Cancer, inflammation and the AT1 and AT2 receptors. J Inflamm (Lond) 2004; 1: 3.
3. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol 2003; 35: 881-900.
4. Mou D, Zhu X, Xu W, Du R. The pathogenetic role of endogenous angiotensin II in stress ulcer in obstructive jaundice rats. Chin Med J (Engl) 1998; 111: 309-312
5. Seno K, Zhu JH, Barrett JD, et al. Cigarette smoke increases gastric ulcer size in part by an angiotensin II-mediated mechanism in rats. Dig Dis Sci 1997; 42: 74-78
6. Yang N, Xu W, Duan J. The decrease of gastric mucosal blood flow in obstructive jaundice under stress. (Chinese.) Zhonghua Yi Xue Za Zhi 1997; 77: 692-694.
7. Bailey RW, Bulkley GB, Hamilton SR, Morris JB, Haglund UH, Meilahn JE. The fundamental hemodynamic mechanism underlying gastric "stress ulceration" in cardiogenic shock. Ann Surg 1987; 205: 597-612.
8. Bhandare PN, Rataboli PV, niz D'Souza RS, Dhume VG. Aggravating action of hydralazine on ethanol-induced gastric lesions. Indian J Physiol Pharmacol 1992; 36: 130-132
9. Bhounsule SA, Pereira JS, Hede SS, niz D'Souza RS. Effect of captopril on oxyphenbutazone and ethanol-induced gastric lesions in rats. Eur J Pharmacol 1990; 177: 87-90.
10. Cullen JJ, Ephgrave KS, Broadhurst KA, Booth B. Captopril decreases stress ulceration without affecting gastric perfusion during canine hemorrhagic shock. J Trauma 1994; 37: 43-49
11. Ender F, Labancz T, Rosivall L. Protective Effects of the inhibition of the renin-angiotensin system against gastric mucosal lesions induced by cold-restraint in the rat. Acta Physiol Hung 1993; 81: 13-18
12. Rao SP, Sathiamoorthy A, Sathiamoorthy SS. Effect of angiotensin converting enzyme inhibitor (captopril) on gastric ulcer production in pylorus ligated rats. Indian J Physiol Pharmacol 1995; 39: 296-298
13. Alekseenko SA, Timoshin SS, Avilova AA, Fleishman MI, Lamekhova VG. Effect of enalapril, lisinopril, and amlodipine on the course of chronic gastrititis in patients with arterial hypertension. (Russian.) Klin Med (Mosk) 2004; 82: 42-45
14. Lendeckel U, Kähne T, Riemann D, Neubert K, Arndt M, Reinhold D. Review: the role of membrane peptidases in immune functions. Adv Exp Med Biol 2000; 477: 21-24.
15. Turner AJ, Hooper NM, Kenny AJ. Metabolism of neuropeptides. Mammalian Ectoenzymes. Amsterdam: Elsevier, 1987; 211-248
16. Kido A, Krueger S, Haeckel C, Roessner A. Possible contribution of aminopeptidase N (APN/CD13) to invasive potential enhanced by interleukin-6 and soluble interleukin-6 receptor in human osteosarcoma cell lines. Clin Exp Metastasis 1999; 17: 857-863
17. Carl-McGrath S, Lendeckel U, Ebert M, Wolter AB, Roessner A, Röcken C. The ectopeptidases CD10, CD13, CD26, and CD143 are upregulated in gastric cancer. Int J Oncol 2004; 25: 1223-1232
18. Kobayashi R, Sun XY, Walsh JH. Angiotensin-converting enzyme in the rabbit stomach wall. Identification in the membrane fraction by affinity purification. Gastroenterology 1991; 100: 25-32.
19. Laliberte F, Laliberte MF, Nonotte I, Bali JP, Chevillard C. Angiotensin I converting enzyme in gastric mucosa of the rabbit: localization by autoradiography, immunoffuorescence, and immunoelectron microscopy. J Histochem Cytochem 1991; 39: 1519-1529
20. Nonotte I, Laliberte MF, Duperray C, et al. Expression of angiotensin I converting enzyme mRNA in rabbit gastric epithelial cells. Mol Cell Endocrinol 1993; 92: 167-174
21. Naim HY. Human small intestinal angiotensin-converting enzyme: intracellular transport, secretion and glycosylation. Biochem J 1993; 296: 607-615
22. Sugimura K, Tian XL, Hoffmann S, Ganten D, Bader M. Alternative splicing of the mRNA coding for the human endothelial angiotensinconverting enzyme: a new mechanism for solubilization. Biochem Biophys Res Commun 1998; 247: 466-472
23. Re R. Intracellular renin-angiotensin system: the tip of the intracrine physiology iceberg. Am J Physiol Heart Circ Physiol 2007; 293: H905-H906.
24. Kumar R, Singh VP, Baker KM. The intracellular reninangiotensin system: a new paradigm. Trends Endocrinol Metab 2007; 18: 208-214
25. Kurdi M, De Mello WC, Booz GW. Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components. Int J Biochem Cell Biol 2005; 37: 1357-1367
26. Brzozowski T, Konturek PC, Konturek SJ, et al. Acceleration of ulcer healing by cholecystokinin (CCK): role of CCK-A receptors, somatostatin, nitric oxide and sensory nerves. Regul Pept 1999; 82: 19-33.
27. Hernandez DE, Nemeroff CB, Orlando RC, Prange AJ Jr. The Effect of centrally administered neuropeptides on the development of stressinduced gastric ulcers in rats. J Neurosci Res 1983; 9: 145-157
28. Konjevoda P, Stambuk N, Aralica G, Pokric B. Cytoprotective Effects of met-enkephalin and alpha-MSH on ethanol induced gastric lesions in rats. J Physiol Paris 2001; 95: 277-281
29. Mercer DW, Cross JM, Smith GS, Miller TA. Protective action of gastrin-17 against alcohol-induced gastric injury in the rat: role in mucosal defense. Am J Physiol 1997; 273: G365-G373.
30. Caughey GH. Mast cell tryptases and chymases in inflammation and host defense. Immunol Rev 2007; 217: 141-154
31. Fang KC, Raymond WW, Lazarus SC, Caughey GH. Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase. J Clin Invest 1996; 97: 1589-1596
32. Nagata N, Niwa Y, Nakaya Y. A novel 31-amino-acid-length endothelin, ET-1(1-31), can act as a biologically active peptide for vascular smooth muscle cells. Biochem Biophys Res Commun 2000; 275: 595-600.
33. Zhao W, Oskeritzian CA, Pozez AL, Schwartz LB. Cytokine production by skin-derived mast cells: endogenous proteases are responsible for degradation of cytokines. J Immunol 2005; 175: 2635-2642
34. Pang L, Nie M, Corbett L, Sutcliffe A, Knox AJ. Mast cell betatryptase selectively cleaves eotaxin and RANTES and abrogates their eosinophil chemotactic activities. J Immunol 2006; 176: 3788-3795
35. Matsuo T, Ikura Y, Ohsawa M, et al. Mast cell chymase expression in Helicobacter pylori-associated gastritis. Histopathology 2003; 43: 538-549
36. Bergin PJ, Anders E, Sicheng W, et al. Increased production of matrix metalloproteinases in Helicobacter pylori-associated human gastritis. Helicobacter 2004; 9: 201-210
37. Koyama S. Significance of cell-surface expression of matrix metalloproteinases and their inhibitors on gastric epithelium and infiltrating mucosal lymphocytes in progression of Helicobacter pyloriassociated gastritis. Scand J Gastroenterol 2004; 39: 1046-1053
38. Yoshimura T, Tomita T, Dixon MF, Axon AT, Robinson PA, Crabtree JE. ADAMs (a disintegrin and metalloproteinase) messenger RNA expression in Helicobacter pylori-infected, normal, and neoplastic gastric mucosa. J Infect Dis 2002; 185: 332-340
39. Buhling F, Peitz U, Kruger S, et al. Cathepsins K, L, B, X and W are Differentially expressed in normal and chronically inflamed gastric mucosa. Biol Chem 2004; 385: 439-445
40. Basque JR, Chenard M, Chailler P, Menard D. Gastric cancer cell lines as models to study human digestive functions. J Cell Biochem 2001; 81: 241-251
41. Catar RA, Muller G, Heidler J, Schmitz G, Bornstein SR, Morawietz H. Low-density lipoproteins induce the renin-angiotensin system and their receptors in human endothelial cells. Horm Metab Res 2007; 39: 801-805
42. Fukata M, Abreu MT. Role of Toll-like receptors in gastrointestinal malignancies. Oncogene 2008; 27: 234-243
43. El-Omar EM. The importance of interleukin 1beta in Helicobacter pylori associated disease. Gut 2001; 48: 743-747
44. Shimada T, Terano A. Chemokine expression in Helicobacter pyloriinfected gastric mucosa. J Gastroenterol 1998; 33: 613-617
45. Li Z, Li J. Local expressions of TGF-beta1, TGF-beta1RI, CTGF, and Smad-7 in Helicobacter pylori-associated gastritis. Scand J Gastroenterol 2006; 41: 1007-1012
46. Carl-McGrath S, Ebert MP, Lendeckel U, Rocken C. Expression of the local angiotensin II system in gastric cancer may facilitate lymphatic invasion and nodal spread. Cancer Biol Ther 2007; 6: May 10 (Epub ahead of print).
47. Dasu MR, Riosvelasco AC, Jialal I. Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivoff Atherosclerosis 2009; 202: 76-83.
48. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16: 225-260
49. Rad R, Dossumbekova A, Neu B, et al. Cytokine gene polymorphisms Influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 2004; 53: 1082-1089
50. Basso D, Plebani M. H. pylori infection: bacterial virulence factors and cytokine gene polymorphisms as determinants of infection outcome. Crit Rev Clin Lab Sci 2004; 41: 313-337
51. Gatti LL, Burbano RR, Zambaldi-Tunes M, et al. Interleukin-6 polymorphisms, Helicobacter pylori infection in adult Brazilian patients with chronic gastritis and gastric adenocarcinoma. Arch Med Res 2007; 38: 551-555
52. Rafiq S, Frayling TM, Murray A, et al. A common variant of the interleukin 6 receptor (IL-6r) gene increases IL-6r and IL-6 levels, without other Inflammatory Effects. Genes Immun 2007; 8: 552-559
53. Taguchi A, Ohmiya N, Shirai K, et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev 2005; 14: 2487-2493
54. Hofner P, Gyulai Z, Kiss ZF, et al. Genetic polymorphisms of NOD1 and IL-8, but not polymorphisms of TLR4 genes, are associated with Helicobacter pylori-induced duodenal ulcer and gastritis. Helicobacter 2007; 12: 124-131
55. Fei BY, Xia B, Deng CS, et al. Association of tumor necrosis factor genetic polymorphism with chronic atrophic gastritis and gastric adenocarcinoma in Chinese Han population. World J Gastroenterol 2004; 10: 1256-1261
56. Garcia-Gonzalez MA, Strunk M, Piazuelo E, et al. TGFB1 gene polymorphisms: their relevance in the susceptibility to Helicobacter pylori-related diseases. Genes Immun 2006; 7: 640-646
57. Jin G, Wang L, Chen W, et al. Variant alleles of TGFB1 and TGFBR2 are associated with a decreased risk of gastric cancer in a Chinese population. Int J Cancer 2007; 120: 1330-1335
58. Suehiro T, Morita T, Inoue M, Kumon Y, Ikeda Y, Hashimoto K. Increased amount of the angiotensin-converting enzyme (ACE) mRNA originating from the ACE allele with deletion. Hum Genet 2004; 115: 91-96
59. Bregonzio C, Armando I, Ando H, Jezova M, Baiardi G, Saavedra JM. Anti-Inflammatory Effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury. Am J Physiol Gastrointest Liver Physiol 2003; 285: G414-G423.
60. Heinemann A, Sattler V, Jocic M, Wienen W, Holzer P. Effect of angiotensin II and telmisartan, an angiotensin1 receptor antagonist, on rat gastric mucosal blood flow. Aliment Pharmacol Ther 1999; 13: 347-355
61. Bregonzio C, Armando I, Ando H, Jezova M, Baiardi G, Saavedra JM. Angiotensin II AT1 receptor blockade prevents gastric ulcers during cold-restraint stress. Ann N Y Acad Sci 2004; 1018: 351-355
62. Sorbye H, Svanes K. The role of blood flow in gastric mucosal defence, damage and healing. Dig Dis 1994; 12: 305-317
63. Tarnawski A, Szabo IL, Husain SS, Soreghan B. Regeneration of gastric mucosa during ulcer healing is triggered by growth factors and signal transduction pathways. J Physiol Paris 2001; 95: 337-344
64. Miyazaki M, Takai S, Jin D, Muramatsu M. Pathological roles of angiotensin II produced by mast cell chymase and the Effects of chymase inhibition in animal models. Pharmacol Ther 2006; 112: 668-676
65. Kao JY, Rathinavelu S, Eaton KA, et al. Helicobacter pylori-secreted factors inhibit dendritic cell IL-12 secretion: a mechanism of inEffective host defense. Am J Physiol Gastrointest Liver Physiol 2006; 291: G73-G81.
66. Carl-McGrath S, Ebert M, Röcken C. Gastric adenocarcinoma: epidemiology, pathology and pathogenesis. Cancer Therapy 2007; 5: 879-894
67. Sugimoto M, Furuta T, Shirai N, et al. Role of angiotensinogen gene polymorphism on Helicobacter pylori infection-related gastric cancer risk in Japanese. Carcinogenesis 2007; 28: 2036-2040
68. Sugimoto M, Furuta T, Shirai N, Ikuma M, Sugimura H, Hishida A. Influences of chymase and angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan. Cancer Epidemiol Biomarkers Prev 2006; 15: 1929-1934
69. Ebert MP, Lendeckel U, Westphal S, et al. The angiotensin Iconverting enzyme gene insertion/deletion polymorphism is linked to early gastric cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 2987-2989